These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 32568450)

  • 1. Modelling neurodegenerative diseases with 3D brain organoids.
    Chang Y; Kim J; Park H; Choi H; Kim J
    Biol Rev Camb Philos Soc; 2020 Oct; 95(5):1497-1509. PubMed ID: 32568450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.
    Venkataraman L; Fair SR; McElroy CA; Hester ME; Fu H
    Stem Cell Rev Rep; 2022 Feb; 18(2):696-717. PubMed ID: 33180261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
    Lee CT; Bendriem RM; Wu WW; Shen RF
    J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics.
    Acharya P; Choi NY; Shrestha S; Jeong S; Lee MY
    Biotechnol Bioeng; 2024 Feb; 121(2):489-506. PubMed ID: 38013504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through.
    Jusop AS; Thanaskody K; Tye GJ; Dass SA; Wan Kamarul Zaman WS; Nordin F
    Front Mol Neurosci; 2023; 16():1173433. PubMed ID: 37602192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system organoids for modeling neurodegenerative diseases.
    Hou PS; Kuo HC
    IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
    Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
    Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional modeling of human neurodegeneration: brain organoids coming of age.
    Grenier K; Kao J; Diamandis P
    Mol Psychiatry; 2020 Feb; 25(2):254-274. PubMed ID: 31444473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling and Targeting Alzheimer's Disease With Organoids.
    Papaspyropoulos A; Tsolaki M; Foroglou N; Pantazaki AA
    Front Pharmacol; 2020; 11():396. PubMed ID: 32300301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases.
    Lei T; Zhang X; Fu G; Luo S; Zhao Z; Deng S; Li C; Cui Z; Cao J; Chen P; Yang H
    Ageing Res Rev; 2024 Dec; 102():102517. PubMed ID: 39321879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease.
    Yin J; VanDongen AM
    ACS Biomater Sci Eng; 2021 Jan; 7(1):254-264. PubMed ID: 33347288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling.
    Centeno EGZ; Cimarosti H; Bithell A
    Mol Neurodegener; 2018 May; 13(1):27. PubMed ID: 29788997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
    Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
    Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome architecture of human-induced pluripotent stem cell-derived three-dimensional organoids as a tool for early diagnosis of neuronal disorders.
    Negi R; Srivastava A; Srivastava AK; Pandeya A; Vatsa P; Ansari UA; Pant AB
    Indian J Pharmacol; 2023; 55(2):108-118. PubMed ID: 37313936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
    Fan W; Sun Y; Shi Z; Wang H; Deng J
    Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Cell Models for Investigating Neurodegenerative Diseases.
    Evangelisti C; Ramadan S; Orlacchio A; Panza E
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances and Applications of Brain Organoids.
    Li Y; Zeng PM; Wu J; Luo ZG
    Neurosci Bull; 2023 Nov; 39(11):1703-1716. PubMed ID: 37222855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.
    Zhang X; Hu D; Shang Y; Qi X
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165431. PubMed ID: 30898538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.